Search Results 681-690 of 21930 for alzheimers
... Alzheimer Cognitive Composite (PACC), in amyloid-positive participants who are asymptomatic at risk for developing Alzheimer's dementia. Participation ...
Clinical Trials · A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease · More about research at Mayo Clinic · Mayo ...
Damage to brain cells in two separate neurodegenerative diseases — Alzheimer's disease and progressive supranuclear palsy — is not limited to specific parts ...
It belongs to a group of human and animal diseases known as prion disorders. Symptoms of Creutzfeldt-Jakob disease can be similar to those of Alzheimer's ...
Memory changes are less common with frontotemporal dementia than with Alzheimer's disease. In FTD, dysfunctional proteins in the brain, called tau or TDP-43, ...
APOE ε4 is a genetic risk factor for mild cognitive impairment and Alzheimer's dementia. However, for APOE ε4 carriers, only computer use and social activities ...
If the scan shows reduced sugar use in the areas of the brain involved in solving problems and remembering, for example, that can be an indicator of Alzheimer's ...
This rare neurological syndrome that's often caused by Alzheimer's disease affects vision and coordination.
Alzheimer's disease. Some research shows that high-dose vitamin E might slow mild to moderate Alzheimer's disease. · Liver disease. Studies show that vitamin E ...
... Alzheimer's Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.